secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACADIA PHARMACEUTICALS INC (ACAD)
CIK:        0001070494
Form:       8-K
Filed at:   2023-06-02T23:59:59+00:00
Accession:  0001193125-23-159833
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acadia shareholders elect three Class I directors, approve say-on-pay, and ratify EY as auditor on annual basis
--------------------------------------------------------------------------------

- Elected James M. Daly, Edmund P. Harrigan, and Adora Ndu as Class I directors (for votes: 108.2M, 126.2M, 131.6M).
- Advisory say-on-pay approved with 87.3M for vs. 48.3M against; broker non-votes 9.9M.
- Stockholders favored annual advisory vote on executive compensation (135.1M votes for 1 year); board adopts annual frequency.
- Ratification of Ernst & Young as independent auditor for FY2023 approved (144.9M for, 0.5M against, 0.1M abstain).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070494/000119312523159833/0001193125-23-159833-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070494/000119312523159833/d474410d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-159833

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer